Matinas BioPharma Holdings, Inc. (MTNB) Form 8-K Material Events
Matinas BioPharma Holdings, Inc. (MTNB) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MTNB
CIK: 1582554
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
EisnerAmper LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerJaime Gilmore
Audit LocationIselin, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-28 | 2026-09-25 | 8-K | 0001493152-26-044451 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-16 | 8-K | 0001493152-26-042954 | View SEC Doc Filr Page |
| 8-K | 2026-09-04 | 2026-08-31 | 8-K | 0001493152-26-041577 | View SEC Doc Filr Page |
| 425 | 2026-08-25 | — | 425 | 0001493152-26-039981 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001493152-26-037748 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-13 | — | SCHEDULE 13D/A Filing | 0000921895-26-002111 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2025-10-16 | OWNERSHIP DOCUMENT | 0000921895-26-002109 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-06-10 | OWNERSHIP DOCUMENT | 0000921895-26-002105 | View SEC Doc Filr Page |
| 425 | 2026-08-04 | — | 425 | 0001493152-26-036000 | View SEC Doc Filr Page |
| 425 | 2026-07-30 | — | 425 | 0001493152-26-035330 | View SEC Doc Filr Page |
| 425 | 2026-07-29 | — | 425 | 0001493152-26-035183 | View SEC Doc Filr Page |
| 8-K | 2026-07-24 | 2026-07-23 | 8-K | 0001493152-26-034601 | View SEC Doc Filr Page |
| 425 | 2026-07-21 | — | 425 | 0001493152-26-034108 | View SEC Doc Filr Page |
| 425 | 2026-07-16 | — | 425 | 0001493152-26-033590 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-14 | — | SCHEDULE 13G Filing | 0001213900-26-077949 | View SEC Doc Filr Page |
| 425 | 2026-07-13 | — | 425 | 0001493152-26-032939 | View SEC Doc Filr Page |
| 8-K | 2026-07-13 | 2026-07-10 | 8-K | 0001493152-26-032938 | View SEC Doc Filr Page |
| 8-K | 2026-06-26 | 2026-06-24 | 8-K | 0001493152-26-030342 | View SEC Doc Filr Page |
| 424B7 | 2026-06-22 | — | 424B7 | 0001493152-26-029586 | View SEC Doc Filr Page |
| S-3 | 2026-06-16 | — | S-3 | 0001493152-26-028881 | View SEC Doc Filr Page |
| 10-Q | 2026-05-08 | 2026-03-31 | 10-Q | 0001493152-26-022010 | View SEC Doc Filr Page |
| 8-K | 2026-04-03 | 2026-04-02 | 8-K | 0001493152-26-015170 | View SEC Doc Filr Page |
| 10-K | 2026-03-31 | 2025-12-31 | 10-K | 0001493152-26-014132 | View SEC Doc Filr Page |
| 8-K | 2026-01-23 | 2026-01-22 | 8-K | 0001493152-26-003445 | View SEC Doc Filr Page |
| 8-K | 2025-12-12 | 2025-12-12 | 8-K | 0001493152-25-027529 | View SEC Doc Filr Page |